Lava Therapeutics Nv earnings were -$26.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest LVTX earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$8.9M, up 1,384.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LVTX reported annual earnings of -$46.6M, with 37.4% growth. The next LVTX earnings date is Nov 14, 2024.
Lava Therapeutics Nv Earnings Reports & History FAQ
What were Lava Therapeutics Nv's earnings last quarter?
On LVTX's earnings call on Invalid Date, Lava Therapeutics Nv (NASDAQ: LVTX) reported Q2 2024 earnings per share (EPS) of -$0.33, up 36.81% year over year. Total LVTX earnings for the quarter were -$8.92 million. In the same quarter last year, Lava Therapeutics Nv's earnings per share (EPS) was -$0.53.
The next LVTX earnings call is Invalid Date. Add LVTX to your watchlist to be reminded of Lava Therapeutics Nv's next earnings date.
What was LVTX's earnings growth in the past year?
As of Lava Therapeutics Nv's earnings date in Invalid Date, Lava Therapeutics Nv's earnings has grown year over year. LVTX earnings in the past year totalled -$26.57 million.
Is Lava Therapeutics Nv profitable or losing money?
As of the last Lava Therapeutics Nv earnings report, Lava Therapeutics Nv is currently losing money. Lava Therapeutics Nv's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$26.00 million, a 41.74% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.